Simplify Logo

Full-Time

Senior Director

FP&a Corporate

Updated on 9/13/2024

Acadia Pharmaceuticals Inc.

Acadia Pharmaceuticals Inc.

501-1,000 employees

Develops therapies for neurological disorders

Biotechnology
Healthcare

Compensation Overview

$215k - $268.6kAnnually

+ Bonus + Equity Awards

Senior, Expert

San Diego, CA, USA

Category
Corporate Finance
Financial Planning and Analysis (FP&A)
Finance & Banking
Required Skills
Communications
Financial analysis
Data Analysis
Requirements
  • Bachelor’s degree in Accounting, Finance, Economics, or Mathematics. CPA/CFA/MBA preferred. 12 plus years of experience in corporate finance, banking, or consulting. Pharma, Biotech, or healthcare industry experience required. An equivalent combination of relevant education and applicable job experience may be considered.
  • Industry specific experience, with extensive understanding of biotech value drivers, including revenue, Commercial operations, clinical development, and portfolio management
  • Financial modeling skills for all stages of biotech programs, including ability to Perform scenario analysis on variety of possible outcomes
  • Strong track record of team building and managerial responsibility
  • Understanding of Generally Accepted Accounting Principles (GAAP)
  • Ability to work in a results-oriented, project-driven, real-time team environment, prioritize projects and deliver quality results within tight time constraints
  • Record of problem solving through data analysis and cross-functional partnership
  • Communicate details and tradeoffs of opportunities in a well thought out manner to senior leadership
  • Ability to be deeply involved in daily operations of the company, not simply view from afar
  • Ability to anticipate issues, ensure data integrity and accuracy of details while being capable of higher-level interpretation and explanation
  • Outstanding communication skills, both verbal and written
  • Experience operating with candid transparency, professionalism, strong emotional intelligence, and the highest degree of integrity
  • Experience with NetSuite and Workday Adaptive Planning a plus
Responsibilities
  • Lead all corporate planning process including annual operating plan, long range plan, sum-of-the-parts, monthly reporting, quarterly earnings call support, and board of directors materials
  • Serve as finance partner to the Business Development deal team. Responsible for maintaining and improving corporate valuation model, acting as finance representative in diligence team meetings, performing extensive financial analysis, and providing strategic input throughout the entire diligence process.
  • Coordinate organizational alignment on resource allocation and strategy
  • Coach and develop corporate FP&A team
  • Communicate real-time changes in assumptions and business trends to leadership. Develop, evolve, and publish regular KPI/metric reporting to track results and identify trends
  • Manage consolidation of financial statements forecasts (P&L, Balance Sheet, Cash Flow)
  • Maintain high level of accuracy and attention to detail in consolidation of corporate reporting
  • Sustain and improve ERP systems and integration with other corporate systems
  • Oversee industry benchmarking and peer set monitoring
  • Build strong relationships with FP&A business partners and other functions within Strategic Finance team, Accounting, cross functional partners, and executive management
Acadia Pharmaceuticals Inc.

Acadia Pharmaceuticals Inc.

View

Acadia Pharmaceuticals develops therapies for neurological disorders, focusing on conditions like Parkinson's disease, schizophrenia, and Rett syndrome. Their products are created through extensive research and development, followed by rigorous clinical trials to ensure safety and effectiveness. Once approved by regulatory bodies like the FDA, these therapies are marketed to patients and healthcare providers. Acadia stands out from competitors by concentrating on areas with significant unmet medical needs and fostering strategic partnerships to enhance their research and market presence. The company's goal is to improve the quality of life for individuals with neurological conditions through effective treatments.

Company Stage

IPO

Total Funding

$813.4M

Headquarters

Dallas, Texas

Founded

1993

Simplify Jobs

Simplify's Take

What believers are saying

  • Acadia's launch of Magnolia's Guide to Adventuring showcases their innovative approach to raising disease awareness and redefining perceptions of Rett syndrome.
  • The acceptance of trofinetide for priority review by Health Canada could lead to significant market expansion and first-mover advantage in treating Rett syndrome in Canada.
  • The appointment of Dr. Elizabeth H. Z. Thompson as Executive Vice President, Head of Research and Development, signals a strong commitment to advancing their R&D capabilities.

What critics are saying

  • The failure of the Phase III ADVANCE-2 trial for pimavanserin in schizophrenia highlights the high-risk nature of drug development in the biopharmaceutical sector.
  • Dependence on regulatory approvals, such as the FDA and Health Canada, introduces uncertainty and potential delays in bringing therapies to market.

What makes Acadia Pharmaceuticals Inc. unique

  • Acadia Pharmaceuticals focuses exclusively on neurological disorders, setting it apart from competitors with broader therapeutic areas.
  • Their commitment to corporate social responsibility, including initiatives like the Rett Sibling Scholarship, enhances their reputation and community engagement.
  • Acadia's strategic partnerships and corporate sponsorships amplify their research capabilities and market reach, distinguishing them from competitors who may not leverage such collaborations.